IP Library Granted Patent US 10,207,240
Granted Patent B2
US 10,207,240 · App. 13/505,646 · Granted Feb 19, 2019

Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly

Inventors: Joseph Jacobson (Newton, MA); Larry Li-Yang Chu (Cambridge, MA); Senthil Ramu (Boston, MA)
Assignee: Gen9, Inc.
B01J19/0046B01L3/502792B82Y30/00B01J2219/0065B01J2219/00378B01J2219/00495B01J2219/00608B01J2219/00621B01J2219/00644B01J2219/00653B01J2219/00659B01J2219/00675B01J2219/00722B01L3/0262B01L3/0268B01L3/5088B01L7/52B01L2300/10B01L2300/1861B01L2400/043B01L2400/0427B01L2400/0439B01L2400/0454C12Q2565/629
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,207,240
App. No.
13/505,646
Granted
Feb 19, 2019
Kind
B2
Abstract

Methods and devices are provided for manipulating droplets on a support using surface tension properties, moving the droplets along a predetermined path and merging two droplets together enabling a number of chemical reactions. Disclosed are methods for controlling the droplets volumes. Disclosed are methods and devices for synthesizing at least one oligonucleotide having a predefined sequence. Disclosed are methods and devices for synthesizing and/or assembling at least one polynucleotide product having a predefined sequence from a plurality of different oligonucleotides having a predefined sequence. In exemplary embodiments, the methods involve synthesis and/or amplification of different oligonucleotides immobilized on a solid support, release of synthesized/amplified oligonucleotides in solution to form droplets, recognition and removal of error-containing oligonucleotides, moving or combining two droplets to allow hybridization and/or ligation between two different oligonucleotides, and further chain extension reaction following hybridization and/or ligation to hierarchically generate desired length of polynucleotide products.

Claims (26)

1. A composition for nucleic acid synthesis, the composition comprising:

water-in-oil emulsion sub-microvolume droplets for synthesis of a target nucleic acid comprising an aqueous phase, an immiscible oil phase, and a surfactant and/or other stabilizing molecules to maintain the integrity of the droplets,

wherein the synthesis of target nucleic acid occurs within the aqueous phase of the water-in-oil emulsion sub-microvolume droplet,

wherein the aqueous phase of each water-in-oil emulsion sub-microvolume droplet comprises a plurality of single-stranded support-bound oligonucleotides each having a predefined sequence, a plurality of single-stranded oligonucleotides in solution having complementary sequences to a terminal region of the plurality of single stranded support-bound oligonucleotides, a thermostable polymerase, a thermostable ligase and a glycerol, wherein glycerol increases the boiling point of the aqueous phase of the water-in-oil emulsion sub-microvolume droplets;

wherein each water-in-oil emulsion sub-microvolume droplet has an aqueous volume of 0.5 picoliters to 100 nanoliters, and

wherein the plurality of single-stranded oligonucleotides in solution together comprise the target polynucleotide.

2. The composition of claim 1 wherein the plurality of single-stranded support-bound oligonucleotides are bound to a solid support selected from the group consisting of a pin, a strip, a plate, a disk, an array, a rod, a particle and a nanoparticle.

3. The composition of claim 1 wherein the plurality of single-stranded support-bound oligonucleotides are bound to one or more beads.

4. The composition of claim 1 wherein the plurality of single-stranded support-bound oligonucleotides have different predefined sequences.

5. The composition of claim 1 wherein the aqueous phase of water-in-oil emulsion sub-microvolume droplet further comprises one or more of deoxyadenosine 5′-triphosphate, deoxythymidine 5′-triphosphate, deoxycytidine 5′-triphosphate, and deoxyguanosine 5′-triphosphate.

6. The composition of claim 1 wherein the aqueous phase of water-in-oil emulsion sub-microvolume droplet further comprises at least one primer.

7. A composition for synthesis of a target polynucleotide comprising:

one or more water-in-oil emulsion sub-microvolume droplets comprising an aqueous phase, an immiscible oil phase, and a surfactant and/or other stabilizing molecules to maintain the integrity of the droplets, wherein the synthesis of the target polynucleotide occurs within the aqueous phase of the one or more water-in-oil emulsion sub-mircovolume droplets;

a plurality of support-bound oligonucleotides contained in the aqueous phase of one or more water-in-oil emulsion sub-microvolume droplets, each support-bound oligonucleotide having a predefined sequence and having a terminal region comprising a sequence identical to a terminal region of another oligonucleotide, the plurality of oligonucleotides together comprise the target polynucleotide;

wherein the aqueous phase of each of the one or more water-in-oil emulsion sub-microvolume droplets further comprises a thermostable polymerase, a primer, deoxyribonucleoside triphosphates, a thermostable ligase and glycerol, wherein glycerol increases the boiling point of the water-in-oil emulsion sub-microvolume droplets and

wherein each water-in-oil emulsion sub-microvolume droplet has an aqueous volume of 0.5 picoliters to 100 nanoliters.

8. The composition of claim 7 wherein the plurality of single-stranded support-bound oligonucleotides are bound to a solid support selected from the group consisting of a pin, a strip, a plate, a disk, an array, a rod, a particle and a nanoparticle.

9. The composition of claim 7 wherein the plurality of support-bound oligonucleotides are single-stranded oligonucleotides having different predefined sequences.

10. The composition of claim 7 wherein the primer is a unique primer or a universal primer.

11. A composition for synthesis of a target polynucleotide comprising:

one or more water-in-oil emulsion sub-microvolume droplets comprising an aqueous phase, an immiscible oil phase, and a surfactant and/or other stabilizing molecules to maintain the integrity of the droplets, wherein the synthesis of the target polynucleotide occurs within the aqueous phase of the one or more water-in-oil emulsion sub-microvolume droplets;

one or more pluralities of single-stranded support-bound oligonucleotides and one or more pluralities of single-stranded oligonucleotides in solution in the aqueous phase of the one or more water-in-oil emulsion sub-microvolume droplets, each plurality of single-stranded oligonucleotides having a different predefined sequence;

wherein the aqueous phase of the one or more water-in-oil emulsion sub-microvolume droplets further comprises a thermostable polymerase, a primer, deoxyribonucleosides triphosphates, a thermostable ligase, and glycerol, wherein glycerol increases the boiling point of the aqueous phase of the water-in-oil emulsion sub-microvolume droplets,

wherein each of the one or more water-in-oil emulsion sub-microvolume droplets has an aqueous volume of 0.5 picoliters to 100 nanoliters, and

wherein a first single-stranded oligonucleotide in solution has a terminal region comprising a sequence complementary to a sequence of a terminal region of the support-bound oligonucleotide, and wherein the first single-stranded oligonucleotide in solution has a terminal region comprising a sequence complementary to a sequence of a terminal region of a second single-stranded oligonucleotide in solution, the plurality of single-stranded oligonucleotides in solution together comprising the target polynucleotide.

12. The composition of claim 11 wherein each of the one or more plurality of single-stranded support-bound oligonucleotides are bound to a solid support selected from the group consisting of a pin, a strip, a plate, a disk, an array, a rod, a particle and a nanoparticle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: GINKGO BIOWORKS, INC.
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 072092/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2025
From: GEN9, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 071945/0972 →
Continuity (4)
Provisional Application 61257591 · Nov 3, 2009
Provisional Application 61264641 · Nov 25, 2009
Provisional Application 61310069 · Mar 3, 2010
Related Publication 20120220497A1 · Aug 30, 2012
Cited By (1)
US 12,441,101